Incidental extravascular findings in CT angiograms in patients post endovascular abdominal aortic aneurysm repair: clinical relevance and frequency

CVIR Endovascular

James Kirk¹  Peter Thurley²  Mario De Nunzio²  Permesh Singh Dhillon²  Peter Bungay²  Mohammad Waleed Butt³  Graham Pollock⁴ 

[1] Clinical Radiology, Queens Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK;Clinical Radiology, Royal Derby Hospital, Derby Teaching Hospitals NHS Foundation Trust, Derby, UK;Radiological Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, UK

关键词: Abdominal aortic aneurysm (AAA);    Endovascular aneurysm repair (EVAR);    Incidental finding;    CT angiogram;   

DOI  :  10.1186/s42155-018-0016-2

学科分类：放射科、核医学、医学影像

来源: Springer

【 摘 要 】

To evaluate the incidence and clinical relevance of extravascular incidental findings (EVIF), particularly malignancies, in planning and follow-up CT angiograms (CTA) of the abdominal aorta in patients who underwent endovascular aneurysm repair (EVAR) of abdominal aortic aneurysm. Retrospective study of 2203 planning and follow-up CTAs of 418 patients who underwent EVAR in a single tertiary centre between 2006 and 2015. CTA reports were scrutinized for EVIFs, which were classified according to clinical relevance, into (I) immediate, (II) potential and (III) no clinical relevance. Clinical follow-up and management were reviewed for significant findings. Follow-up CTAs of patients with incidental malignancies were re-reviewed by two consultant radiologists to evaluate if early missed malignant findings on previous CTAs were present. In total, 950 EVIFs were noted in 418 patients [31 females (7.4%), 387 males (92.6%); age range 63–93, mean age 79.0 years]. The number of patients with findings in each category were; Category I (115), Category II (165), Category III (304). Incidental malignant findings were reported in 51 patients (12.2%), of which 27 were noted on the initial CTA (6.5%) and 24 on follow-up CTAs (5.7%). Of the 24 patients with malignancies on follow-up CTAs, 13 had early malignant findings missed or misinterpreted on previous CTAs, while 11 had no significant abnormality even on retrospective review. A high number of significant EVIFs, particularly incidental malignancies, can be identified in follow-up CTAs of patients who undergo EVAR. Specific ‘review areas’ when reporting surveillance CTAs can be recommended based on the findings of our study.

【 授权许可】

CC BY